TIAA CREF Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-66,533
Closed -$9.32M 3039
2018
Q4
$9.32M Sell
66,533
-1,448
-2% -$220K 0.01% 979
2018
Q3
$11.6M Sell
67,981
-4,367
-6% -$734K 0.01% 1024
2018
Q2
$12.6M Buy
72,348
+4,416
+7% +$664K 0.01% 1003
2018
Q1
$7.84M Sell
67,932
-312
-0.5% -$33.2K 0.01% 1275
2017
Q4
$5.75M Sell
68,244
-3,437
-5% -$287K ﹤0.01% 1522
2017
Q3
$6.6M Buy
71,681
+16,695
+30% +$1.3M ﹤0.01% 1447
2017
Q2
$4.41M Buy
54,986
+14,214
+35% +$788K ﹤0.01% 1674
2017
Q1
$1.72M Buy
40,772
+3,614
+10% +$149K ﹤0.01% 2225
2016
Q4
$1.19M Sell
37,158
-2,495
-6% -$64K ﹤0.01% 2440
2016
Q3
$1.04K Buy
39,653
+327
+0.8% +$8.56K ﹤0.01% 2522
2016
Q2
$912K Buy
39,326
+10,620
+37% +$264K ﹤0.01% 2560
2016
Q1
$785K Buy
28,706
+2,113
+8% +$44.2K ﹤0.01% 2606
2015
Q4
$757K Buy
26,593
+805
+3% +$21.6K ﹤0.01% 2739
2015
Q3
$451K Hold
25,788
﹤0.01% 2913
2015
Q2
$465K Buy
25,788
+4,757
+23% +$65K ﹤0.01% 2983
2015
Q1
$262K Hold
21,031
﹤0.01% 3030
2014
Q4
$247K Buy
21,031
+16,152
+331% +$188K ﹤0.01% 3077
2014
Q3
$64K Buy
+4,879
New +$63.3K ﹤0.01% 3115

Other funds holding LOXO

TIAA CREF Investment Management's LOXO Position: Q1 2019 in Review

TIAA CREF Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 66,533 shares — an estimated $9.32M sold.

TIAA CREF Investment Management first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $12.6M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • TIAA CREF Investment Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • TIAA CREF Investment Management sold 66,533 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.32M.
  • TIAA CREF Investment Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
  • TIAA CREF Investment Management's Loxo Oncology, Inc position peaked at $12.6M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.